NCT00351702View on ClinicalTrials.gov

Preventive Therapy for Tuberculosis in HIV Infected Persons

PHASE3CompletedINTERVENTIONAL
Enrollment

683

Participants

Timeline

Start Date

February 28, 2001

Primary Completion Date

September 30, 2008

Study Completion Date

June 30, 2011

Conditions
Human Immunodeficiency VirusTuberculosis
Interventions
DRUG

Isoniazid with Ethambutol

Isoniazid (300mg) with Ethambutol (800mg) daily for 6 months

Trial Locations (1)

600 031

Tuberculosis Research Centre, Chennai

All Listed Sponsors
collaborator

United States Agency for International Development (USAID)

FED

lead

Tuberculosis Research Centre, India

OTHER_GOV

NCT00351702 - Preventive Therapy for Tuberculosis in HIV Infected Persons | Biotech Hunter | Biotech Hunter